POET Technologies Inc  

(Public, CVE:PTK)   Watch this stock  
Find more results for Christopher LaFrance
2.44
+0.43 (21.39%)
Apr 22 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.72 - 2.46
52 week 0.31 - 2.87
Open 1.76
Vol / Avg. 5.99M/1.47M
Mkt cap 371.03M
P/E     -
Div/yield     -
EPS -0.06
Shares 152.06M
Beta 1.32
Inst. own     -

Key stats and ratios

Q3 (Sep '13) 2012
Net profit margin -2696.24% -1625.96%
Operating margin -2696.24% -1625.96%
EBITD margin - -1622.88%
Return on average assets -150.98% -97.46%
Return on average equity -160.11% -161.03%
Employees 29 -
CDP Score - -

Address

Suite 501, 121 Richmond St. W
TORONTO, ON M5H 2K1
Canada
+1-416-3689411 (Phone)
+1-416-8610749 (Fax)

Website links

Description

POET Technologies Inc., formerly OPEL Technologies Inc., operates as a fabless semiconductor company. The Company develops a process for integrating optical and electronic devices on a single chip, the planar opto-electronic technology (POET) a semiconductor platform. The Company conducts developmental activities, through its ODIS Inc. (ODIS) facility, for an array of devices for potential military, consumer, commercial, and industrial applications, built on its III-V (gallium-arsenide) POET semiconductor platform.ODIS develops gallium arsenide-based processes and semi-conductor microchip products having several market applications: infrared sensor arrays for homeland security monitoring and imaging along with the combination of optical lasers, and electronic control circuits on the same microchip for applications in various military programs and telecom for, fibre to the home. The Company operates geographically in the United States and Canada.

Officers and directors

Peter Copetti Executive Chairman of the Board, Interim Chief Executive Officer
Leon M. Pierhal President, Director
Mark Benadiba Vice Chairman of the Board
Age: 60
Kevin Barnes Chief Financial Officer, Treasurer
Blaine Grisel Controller
Michel J. Lafrance Secretary
John F. O'Donnell Director
Geoff Taylor Director
Adam Chowaniec Ph.D. Independent Director
Samuel Peralta Independent Director